Azitra, Inc. (@azitrainc) header
Azitra, Inc. (@azitrainc) profile picture

Precision dermatology powered by microbial and genetic engineering Developing novel therapeutics to treat adverse skin conditions and disease

Branford, CT
Joined November 2015
Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)
Azitra, Inc. retweeted
In an exclusive interview with The Fly, @azitrainc CEO spoke about the company's expanding #strategy, the science behind its recombinant #protein programs and the commercial potential of ATR COSF. More in "Meet the Company," from @theflynews $AZTR thefly.com/AZTR
1
1,323
Azitra, Inc. retweeted
Replying to @azitrainc
@azitrainc's co-founder & Chief Operating Officer, Travis Whitfill, outlines the pathway forward for a cosmeceutical in contrast to a pharmaceutical product. $AZTR #Cosmeceuticals #SkinBarrier #Filaggrin #Dermatology #SkincareScience #SkinMicrobiome youtube.com/shorts/NQHPISIW0…
1
333
There are reports circulating around Azitra with respect to issuance of stock by the company. These reports are false. Please refer to our IR page for official press releases and more information: ir.azitrainc.com/ $AZTR
4
3
2
8
1,741
Azitra, Inc. retweeted
Reminder - be sure to listen to CEO Francisco Salva on the #EmpoweredPatient #podcast - speaking about our innovative technology to deliver precision dermatology powered by microbial & genetic engineering: empoweredpatientradio.com/ad… #NethertonSyndrome #RareDisease #CancerRash
1
1
228
ATR04-484 inhibited both methicillin-sensitive and methicillin-resistant Staphylococcus aureus bacteria strains, which are associated with rash in patients with cancer. #oncology | @YaleCancer hubs.li/Q03wlTg50
1
1
411
.@twhitfill @azitrainc discusses Netherton syndrome, the company’s platform technology for engineering live biotherapeutic products, and why it takes more than simply inserting a gene into a desired bacteria to produce these treatments. globalgenes.org/raredaily/en…
1
1
1
73
Looking forward to presenting next week at the Microbiome Times Forum in Brussels! @azitrainc $AZTR ir.azitrainc.com/news-releas…
1
2
2
656
Excited to be at BIO next in San Diego! I'll be presenting Wednesday 6/5 at 12p PT a corporate update for Azitra $AZTR ir.azitrainc.com/news-releas…
2
5
2,923
I'm excited to give more updates this Friday at the Society of Investigative Dermatology meeting in Dallas on our platform and especially ATR-04 for EGFRi-driven toxicities #SID2024 $AZTR
1
1
5
2,496
I'll be presenting updated preclinical data for Azitra's platform and Netherton syndrome at #ASGCT24 this Friday. Can't wait! $AZTR
1
3
4
6
4,978
Really cool stuff. Check out this review paper on engineered bacteria that came out last month in @NaturePortfolio highlighting the landscape of engineered bacteria for treating skin dieseases: nature.com/articles/s41522-0… (Our work at @azitrainc highlighted in there, too!) $AZTR
Interesting approach for acne treatment: engineer bacteria to work like Accutane, but locally (and without all the nasty side effects)! Modified C. Acnes bacteria secrete NGAL to kill sebocytes & thus sebum production. They engraft on mice skin & produce NGAL there.
3
7
1,730
Headed to Boston to give a talk at the @MicrobiomeDaily Drug Development conference! Will be giving exciting updates on @azitrainc’s platform as we prepare for a clinical trial in Netherton syndrome. microbiome-summit.com
1
4
Azitra, Inc. retweeted
We are excited to have @twhitfill joining us Tuesday on our #VirtualBreafast Series! He checks so many boxes - entrepreneur, investor, professor, #30Under30. This is going to be exceptional Register here https://teapawt.net/t.co/CaJeXW4Nld Thanks to @CooleyLLP for sponsoring this month!
1
3
1
5
NEW INTERNSHIP POSTED: @azitrainc has posted a new intern position for a Business Strategy Intern. Applications are now open for the Summer of 2022. Interested in applying? Visit lifescisprints.com/internshi….
1
2
Dive into the latest op-ed from Head of Leaps, Juerg Eckhardt, highlighting our commitment to advancing therapies for #autoimmune diseases and chronic inflammation through portfolio companies like @azitrainc, @EdificeHealth, Deka, @gro_bio, and @Mozart_tx.

1
5
55
Honored that @azitrainc is on this list!
Congratulations to Wellinks for being in the Top 25 Greater New Haven tech companies! Via #NewHavenBiz. lnkd.in/g3DbVYxr
1
7
Thank you Ashley!! We’re looking for a VP of Research at @azitrainc. We’ve got a great team and awesome lab with room to grow in Groton, Connecticut Check out more here: azitrainc.com/contact/#caree…
This Post is from an account that no longer exists. Learn more
1
3
My favorite Ginkgo program is our (@azitrainc's) collaboration with them to make living, bioengineered mosquito repellants! Funded by @DARPA cen.acs.org/biological-chemi…
It's going to be a very exciting month for us! To kick it off, we wanted to send y'all some swag bags (incl. a water bottle, t-shirt, stickers and copies of @growbyginkgo). To enter into our little giveaway, QT this with your favorite Ginkgo cell program or one you'd love to see!
1
3
TIP Spotlight: @azitrainc is a medical dermatology company that leverages its extensive knowledge of proteomics, genetic engineering and the skin microbiome to create and develop novel products for the treatment of skin conditions. Learn More: azitrainc.com/
1
5
Amazing panel this morning to kick off the Microbiome Drug Development Summit with CEOs of @VedantaBio (@bernatolle), Kaleido Therapeutics, @finch_tx, @SeresTX, and Persephone Therapeutics and @KenBlountPhD from @ferring moderated by Denise Kelly of @SeventureP. $FNCH $MCRB
Our Co-founder and Executive Director of Advanced Technology @twhitfill is chairing the 6th Microbiome Movement - Drug Development Summit, June 29-July 1. Learn about the new generation of #microbiome therapeutics. #MicrobiomeMovement @MicrobiomeDaily lnkd.in/ddhHiQJ
2
4